New Approach Against Antibiotic-resistant Bacteria in CF Patients Shows Promise in Phase 1 Trial
Researchers may have found a new way of treating antibiotic-resistant bacterial infections, specifically Pseudomonas aeruginosa, in the...
Sound Pharmaceuticals to present initial data on the STOP Ototoxicity Study at Cystic Fibrosis Confe
Sound Pharmaceuticals (SPI) is pleased to announce that its recent submission to the upcoming North American Cystic Fibrosis Conference...
Chronic P. Aeruginosa Infection Greatly Raises Risk of Flares in Non-CF Bronchiectasis, Study Shows
People with non-cystic fibrosis (CF) bronchiectasis are at a significantly greater risk of exacerbations if they have chronic infections...
Understanding antibiotic resistance in patients with cystic fibrosis
A defective gene causes thick, sticky mucus to build up in the lungs of patients with cystic fibrosis (CF). There, it traps bacteria,...
#NACFC — Sound Pharmaceuticals to Present Preliminary Data on Ototoxicity Study
Sound Pharmaceuticals (SPI) will present data on the incidence and severity of ototoxicity in cystic fibrosis (CF) patients who received...
MS1819-SD Shows Positive Results for Exocrine Pancreatic Insufficiency in Phase 2a Trial
AzurRx BioPharma, in partnership with Mayoly Spindler, announced that a recent Phase 2a clinical trial testing MS1819-SD as a potential...
Vertex and Treating CF: High Hopes for Triple Combinations and Gene Therapy Possibilities
Editor’s note: This is third in a four-part series looking at Vertex Pharmaceuticals and its “all in for CF” approach. Here, we look at...
Does Monotherapy With Correctors Have Clinical Benefit in Cystic Fibrosis?
Insufficient evidence exists to demonstrate that monotherapy with correctors has clinically important effects in individuals with cystic...
Dietary Flavonoids May Help in Managing CF Through Impact on Gut Bacteria, Small Study Suggests
Consuming dietary flavonoids — compounds naturally found in fruits, vegetables, chocolate, and beverages like wine and tea — may be...
